GAIA AG

We are global pioneers in digital therapeutics, successfully launching our first product in 2001. Our mission is to develop clinically validated digital therapeutics that empower patients, payers, and physicians with effective, FDA cleared products that have the same effect sizes as drugs. Our products are created by our team of multidisciplinary experts, covering all competencies required to develop, launch and maintain top-of-class products for major markets. Our team includes experienced physicians and psychotherapists, clinical scientists experienced in orchestrating Phase II & III trials, IT and software engineers, regulatory affairs experts as well as market access specialists.